Temple University
Open enrollment across a mixed-phase pipeline
According to ClinicalTrials.gov-derived indexes, Temple University sits in the top decile of US sponsors by registered trial count (#180 of 15,742 sponsors by registered trial count).
Temple University: 163 sponsored US clinical trials, 21 recruiting.
Temple University sponsors 163 registered US clinical trials on ClinicalTrials.gov, 21 of them currently recruiting, and 128 completed. 18 of these trials are in Phase 3-4 (later-stage) and 25 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Obesity, with 6 trials.
Top-decile sponsor footprint
Temple University ranks in the top decile of sponsors by registered trial count (#180 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
128 of 134 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (95.5%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
163 total, page 3 of 4
Study of Procoagulation Markers in Stroke Patients
NCT01811550
Feeding, Fun, and Families Study
NCT03646201
School Breakfast Policy Initiative Study
NCT01924130
Balance and Posture in Adults With Cerebral Palsy
NCT01585571
Kids Safe and Smokefree (KiSS)
NCT01745393
Healthy4Baby: Preventing Postpartum Weight Retention Among Low-Income, Black Women
NCT01530776
A Novel Prosocial Online Support Group for Distressed Breast Cancer Survivors
NCT01396174
Visual Feedback to Improve Balance During Walking
NCT01690611
Effects of Weight Loss on Foot Structure and Function in Obese Adults: A Pilot Study
NCT01782144
Korean CRC Screening Study PT13599
NCT04478110
Telephone Based Management of Hyperlipidemia
NCT01212159
Treatment for Young Adults With Anorexia Nervosa
NCT01190423
Cognitive Behavioral Aggression Treatment
NCT01264900
Temple Registry for the Investigation of African American Gastrointestinal Disease Epidemiology
NCT01262755
Miralax (PEG 3350) vs. Golytely as Bowel Preparation for Screening Colonoscopy
NCT01170754
Kaletra and Maraviroc in Antiretroviral Therapy (ART)-Naive Patients (KALMAR Study)
NCT01068873
The Effects of a Pre-packaged, Portion Controlled Meal Plan on Type 2 Diabetes and Glycemic Control: A Comparison Study
NCT01260337
A Weight Loss Trial for Emotional Eating
NCT02055391
Stepped Care Treatment for Binge-Eating
NCT00965705
A Randomized Trial of the Early Referral and Request Approach (ERRA) Intervention to Increase Consent to Organ Donation
NCT02138227
Enhancing Diabetic Foot Education by Viewing Personal Plantar Pressures
NCT01941719
Dose Response of Intravenous Sincalide(CCK-8) for Gallbladder Emptying
NCT00685477
Cosmetic Outcomes of Absorbable Versus Non-absorbable Sutures in Pediatric Facial Lacerations
NCT00681070
Dynamic Plantar Microvascular Skin Response to Compressive Loads in At-risk Diabetic and Healthy Control: a Pilot Study
NCT01580917
Healthy Corner Store Initiative
NCT00593749
Improving Outcomes in Underserved Women With GDM
NCT00774124
Rapid HIV Testing Program in the Emergency Department
NCT00548041
Pilot Study to Assess Pre-packaged, Portion-controlled Meal Plan on Weight Loss
NCT00593476
Strict Glycemic Control by Insulin Infusion:Observations on Emergency Department Initiation
NCT00779701
Smoking Cessation in NYC
NCT04489524
Ameliorating Attention Problems in Children With Sickle Cell Disease (SCD)
NCT01411280
The Breakfast Study
NCT00593307
Intake Promoting Effects of Large Portions in Children
NCT00436878
Life After Cancer: Behavioral Treatment Study to Improve Quality of Life
NCT00473941
Rabeprazole Protection of Aspirin Induced Gastric Damage.
NCT00220857
Tricyclic Antidepressants (TCAs) on Gastric Emptying
NCT00220844
Lansoprazole Preventing Gastroduodenal Stress Ulcerations
NCT00220909
Electrogastrogram (EGG) Reproducibility Study: EEG Readings in Normal Subjects and Dyspeptic Patients
NCT00220883
Weight and Metabolic Effects of an Almond Enriched Hypocaloric, Low Fat Diet on Overweight and Obese Persons
NCT00194428
Oral Health Education Program
NCT00103493
Prostate Cancer Education in African American Men
NCT01415375
Healthetech, Inc. SMART Study
NCT00194194
Counseling to Reduce Children's SHS Exposure: A Trial With Maternal Smokers
NCT02117947
Preventing Heart Disease in Underserved Patients
NCT00778804
Pennsylvania Study Of Chronic Obstructive Pulmonary Exacerbations
NCT00774176
Adding Cognitive Behavioral Therapy to Drug Treatment for Social Anxiety Disorder
NCT00074802
Cognitive Function and Cue-Reactivity Study
NCT00194246
Placebo Controlled Trial of Botulinum Toxin for Gastroparesis
NCT00372970
Fat Induced Insulin Resistance and Atherosclerosis
NCT02348190
The Safety and Effectiveness of Low and High Carbohydrate Diets
NCT00079547
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 8 |
| Phase 2 | 17 |
| Phase 3 | 5 |
| Phase 4 | 13 |
Therapeutic Areas
What is open in the Temple University pipeline
21 recruiting of 163 indexed (13% open); 128 completed (79%).
Phase mix: 18 late (III/IV) vs 25 early (I/II) (balanced across stages).
Top condition: Obesity (6 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Temple University: open-pipeline peers nationwide
Peers matched on 163 registered trials and 13% open enrollment, not the therapeutic-area sidebar.
Temple University sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 163 trials (± recruiting share)
- Tufts University · 163 trials · 6% recruiting
- Wayne State University · 163 trials · 13% recruiting
- Alexion Pharmaceuticals · 162 trials · 10% recruiting
- University of Vermont · 162 trials · 9% recruiting
Sponsors near 13% open enrollment (± trial volume)
- McMaster University · 13% recruiting · 31 trials
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) · 13% recruiting · 93 trials
- University of Pittsburgh · 13% recruiting · 1,238 trials
- Intermountain Health Care · 13% recruiting · 85 trials
Related
What to do with this Temple University page
163 registered trials is a research-attention snapshot, not an endorsement of Temple University or any single study.
- 21 of Temple University's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Obesity is the condition Temple University studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Obesity trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Temple University pipeline card: 163 registered trials from official public datasets.Report a data error.